Abstract A recent study has shown that cryptogenic stroke can occur even in patients with small or insignificant atrial septal defects (ASD). However, clinical experience in this field is still limited in Japan, also the efficacy and safety of catheter closure of such defects have not been identified. To evaluate the efficacy and safety of catheter closure of interatrial communication in patients with cryptogenic stroke, 13 patients who were diagnosed with cerebrovascular events due to cryptogenic embolism were included in this study. Mean age at procedure was 43 ± 15 (range 17-68) years. In all patients, the presence of spontaneous or provoked interatrial right-to-left shunts was demonstrated by transesophageal contrast echocardiography. Mean defect size evaluated by the balloon sizing technique was 9.2 ± 2.8 mm, and mean size of the Amplatzer Septal Occluder deployed was 9.5 ± 2.8 mm. Devices were successfully deployed in all patients, though one device migrated into the descending aorta was retrieved by a snare catheter. Complete closure was detected by transesophageal contrast echocardiography at 12 months after the procedure was in 11 (85%) of the 13 patients. During the follow-up period (30.1 ± 9.4 months), no recurrent thromboembolic event was observed. Catheter closure of interatrial right-to-left communications can be safely performed. This procedure may contribute to reduction or prevention of recurrent neurological events in this patient population.
Introduction
Since 2005, catheter closure of an atrial septal defect (ASD) was introduced in Japan, clinical experience of this procedure has spread from the pediatric to adult population [1] . However, published data for adult patients with this disease have still been limited in Japan due to the approval process of institutional criteria. In our institution, 430 patients with ASD have been treated by catheter closure, and more than 60% of these patients were adults ([20 years of age). With the accumulation of clinical experiences of catheter closure of ASD in adults, we have sometimes encountered ASD patient with stroke who were complicated.
It is well known that the patent foramen ovale (PFO) remains in 15-25% of adults [2, 3] and is highly associated with cryptogenic stroke [4] [5] [6] , especially when combined with atrial septal aneurysm (ASA) [7, 8] . However, a recent study showed that cryptogenic stroke can occur even in patients with ASD [9] because a right-to-left shunt may develop in normal individuals due to transient elevation in right atrial pressure during early ventricular systole and/or with the Valsalva maneuver in the case of a small ASD. It is reported that there are considerable variations in morphology of PFO [10] . In fact, definite discrimination between PFO and small ASD is sometimes difficult in echocardiography as well as in a surgical view. There has been no published report in Japan on clinical experiences of catheter closure of small or insignificant ASDs in patients with cryptogenic stroke.
The purpose of this study was to evaluate the safety and efficacy of our initial experience of catheter closure of interatrial communications in patients with cryptogenic stroke.
Methods
Between August 2005 and November 2010, 430 patients with ASD underwent catheter closure in our institution. Amplatzer Septal Occluder (ASO) (AGA Medical Corporation, Plymouth, MN, USA) was used in all procedures. Among these patients, 13 patients who had a previous history of cerebral infarction or transient ischemic attack (TIA) which occurred as a result of cryptogenic embolism were included in this study.
The diagnosis of ischemic stroke was based on symptoms and signs of neurologic deficit and corresponding findings by computed tomography or magnetic resonance imaging scans. TIA was defined as a focal neurologic deficit resolving completely within 24 h. At least one ischemic stroke or TIA was documented in all of the 13 patients. Magnetic resonance angiography was performed and intracranial artery stenosis appropriate to the patient's symptoms and stenosis in carotid or vertebral artery was not demonstrated in all patients.
In all of the 13 patients, interatrial left-to-right shunts were identified by transthoracic or transesophageal echocardiography at rest, and spontaneous or provoked interatrial right-to-left shunts (with or without ASA) were also demonstrated by transesophageal contrast echocardiography.
The diagnostic decision of ''cryptogenic stroke'' was made with the agreement of the referring neurologist and cardiologists in our hospital under the consideration of all the examination results.
The mean duration from the last episode of cerebrovascular events to the catheter closure procedure was 10.4 ± 9.6 months. All patients were given information about the risks and benefits of not only catheter treatment but also conventional medical treatment and the patients gave written informed consent.
Patient characteristics are shown in Table 1 . None of the patients were complicated with atrial fibrillation, and the existence of supraventricular arrhythmia, which could be a risk for a cerebrovascular event, was not demonstrated in any of the patients by examinations such as Holter monitoring. For pre-interventional diagnosis, pre-interventional guidance, and post-interventional follow-up, an Aloka Prosound ALPHA 10 echocardiography system (Aloka Co, Ltd, Tokyo, Japan) or a Philips IE 33 echocardiography system (Philips Medical Systems, Andover, MA, USA) with a multiplane probe and with a fully sampled matrix array transducer probe was used.
Transesophageal echocardiography (TEE) was performed to visualize the interatrial septum and exclude the possibility of thrombi or other structural abnormalities. The criteria for diagnosis of ASA diagnosed by TEE included diameter at the base ›15 mm and excursion of the septum secundum with an amplitude [15 mm. Interatrial right-toleft shunt was defined as the appearance of microbubbles across the interatrial septum (with or without the Valsalva maneuver) or a definite sign on a color Doppler image indicating interatrial right-to-left shunt. Hand-agitated air bubbles were used for the contrast agent. The option of catheter closure of ASD was offered by a neurologist to the patient if an interatrial right-to-left shunt was confirmed by TEE and no other cause for ischemic stroke had been found.
The procedure was performed under general anesthesia with the assistance of TEE and fluoroscopy. Balloon sizing with the stop-flow technique by an AGA sizing balloon (AGA Medical Corporation, Plymouth, MN, USA) was used for device selection.
After the diagnostic procedure had been completed, a long sheath (size ranging from 8F to 10F) was placed in the atrial septum. The selected device, which was the same or 1 mm larger than the balloon sizing, was mounted on the delivery system and loaded into the transseptal sheath. Then the device was delivered through the sheath into the left atrium until the left atrial part of the device was unfolded. The whole unit was then withdrawn under fluoroscopic and transesophageal echocardiographic monitoring against the interatrial septum. After it had been determined that the device was in the correct position and was stable, the device was unscrewed and released.
To prevent infectious complications, all patients received antibiotic prophylaxis. Cefazolin at 1 g was intravenously administered 30 min before the procedure and 6 h later. All patients were discharged from the hospital within 4 days after the procedure.
All patients received acetylsalicylic acid at 100 mg daily for at least 6 months. Seven patients were treated also with a vitamin K antagonist and adjusted to a target international normalized ratio of 2.0-3.0. The other 6 patients were treated also with clopidogrel 75 mg a day for 6 months. No other anticoagulation drugs or anti-platelet drugs were used during the follow-up period.
Transthoracic echocardiography (TTE) study was performed 1 day after the catheter closure. After discharge from the hospital, clinical examinations, including neurological and medical examination and TTE were carried out at 1, 3 and/or 6, 12, 24 months. TEE with contrast air bubble study at rest and the Valsalva maneuver were performed at 3 and/or 6, 12 and 24 months after catheter closure.
Statistical analysis
Data are presented as means ± SD (Microsoft Excel, Redmond, WA, USA).
Results

Baseline characteristics and procedural results
A total of 13 patients were included in this study. Mean age at procedure was 43 ± 15 (range 17-68) years. Nine patients (69%) were female. Five patients (38%) were complicated with ASA.
Procedures were successful in all 13 patients. Deployed device sizes are shown in Table 2 . Mean defect size evaluated by the balloon sizing technique was 9.2 ± 2.8 (range 5-15) mm. Mean deployed device diameter was 9.5 ± 2.8 (range 6-15) mm. No patients developed atrial arrhythmias during or after the procedure. One patient (case 10) was complicated with device migration into the descending aorta. In this patient, the atrial septum was very floppy and was complicated with ASA. Initial balloon sizing diameter was judged to be 10 mm, and a 10-mm device was implanted as routine manipulation. However, the device was not stable due to the floppy septum, and it migrated into the descending aorta about 5 min after deployment. The device was successfully retrieved by a gooseneck snare kit from the right femoral artery. Repeated balloon sizing revealed that the stretch diameter was 15 mm, and a 15-mm device was successfully deployed. No other complication was observed during or immediately after the procedure.
Follow-up
All patients completed more than 12 months of follow-up. The mean follow-up period was 30.1 ± 9.4 months. During the follow-up period, no recurrent cerebrovascular event was observed. TEE with contrast bubble study was performed in all patients during the follow-up. Complete closure of the right-to-left shunt through the ASD by TEE was achieved in 11 (85%) of the 13 patients. Complete closure was demonstrated in 5 patients at 3 months, in 5 patients at 6 months and in 1 patient at 12 months after the procedure. In case 1, the interatrial right-to-left shunt remained unclosed at 24 months after the procedure. Follow-up TEE findings with contrast bubble study suggested the presence of multi-fenestrated defects in the inferoposterior rim. In case 10, at 6 months of follow-up, a leftto-right residual shunt was demonstrated by TEE with color Doppler image, although result of a contrast bubble study with the Valsalva maneuver by TEE was negative. In all patients, residual left to right shunt was not demonstrated by TTE with color Doppler image. Five patients discontinued anticoagulation or anti-platelet medical therapy after consultation with neurologists. Those 5 patients were followed-up for a mean period of 25.2 ± 4.8 months, and no recurrent cerebrovascular event or event suggesting systemic embolism was observed during the follow-up period. 
ASA atrial septal aneurysm, DVT deep vein thrombosis, CI cerebral infarction, TIA transient ischemic attack
Discussion
Ischemic stroke is one of the leading causes of death and long-term disability worldwide. Cerebrovascular events are the third leading cause of death among adults in Japan, and more than half of them are events of ischemic stroke. Aggressive measures for primary prevention are crucial, though secondary prevention is equally important for survivors of ischemic stroke or transient ischemic attack [11] . In some patients, etiology of stroke remains unknown and it is referred to as cryptogenic stroke [12] . Cryptogenic stroke was reported to be associated with PFO, which is a major right-to-left shunt in adults. The association was confirmed in a recent meta-analysis of case control studies [8] and in a prospective PFO study. In Japan, it was reported that at least 5% of acute ischemic stroke patients had definite right-to-left shunt through the interatrial communication [13] .
However, recent studies have demonstrated that not only PFO but also ASD may be a risk for cryptogenic stroke [9] . Such ASD is usually a small defect and/or complicated with ASA, allowing right-to-left shunt of blood at the time of elevated right atrial pressure [14] . Clinically, there are some interatrial communication types for which it is difficult to distinguish PFO from ASD. For instance, interatrial communication such as a spontaneous small leftto-right shunt that has been demonstrated by color Doppler imaging might be such cases.
In this study, all patients had left-to-right shunts at rest, and the existence of interatrial right-to-left shunts was also detected by contrast echocardiography with or without the Valsalva maneuver. These cases could be called ''small ASD'' and might be distinguished from classical PFO. Like these ''small ASD'' interatrial communications, there are cases in which an ASO device might be even more suitable than other devices that are designed especially for PFO closure [15, 16] . Interestingly, recent data from the United States have also reported Amplatzer ASD devices were commonly used (about 40% of the procedures) even for patients with PFO [17] . In patients complicated with ASA, ASD devices probably have structural advantages for stable deployment compared to PFO devices in this morphological situation or procedures. We also found that balloon sizing was extremely important when closing small interatrial defects. Precise measurement of the size of defect was crucial, especially when using ASO device.
There is a growing body of evidence suggesting a correlation of PFO with stroke not only in young adults but also in older patients [18, 19] . However, no device specific for PFO closure after cryptogenic embolism has been approved by the US Food and Drug Administration [20] [21] [22] . As in the United States, no device specific for PFO closure has been approved in Japan. Amplatzer Septal Occluder and Amplatzer Cribriform Device (AGA Medical Corporation, Plymouth, MN, USA) are the only devices approved for clinical use for closure of interatrial communications.
It is suggested that many of the recurrent strokes may not be due to cryptogenic embolism related to interatrial communication [23] . Other mechanisms aside from cryptogenic embolism have been proposed as pathogenesis even among the proportion of patients in whom a stroke is indeed attributed to interatrial communication. According to the fact that many recurrent strokes are not attributed to interatrial communications the potential benefit for closure is limited, and some patients might benefit from closure of Major complication Cerebrovascular event interatrial communication and others might be harmed. Thus, the careful patient selection of the candidates for catheter closure is crucial [24] . Meanwhile, there is also a growing body of evidence suggesting the efficacy of catheter closure of PFO [25] [26] [27] . Although there is no published report of randomized control trial using Amplatzer Septal Occuluder, a few reports of non-randomized trials suggest that risk of recurrent stroke is even or lower after catheter closure of interatrial communication compared to medical therapy [28] [29] [30] . However, there are still limited published data about the efficacy of ASO devices for closure of interatrial right-to-left shunts with the aim of preventing recurrent cryptogenic embolism and their actual results. The results of this study suggest the utility and safety of this device for closure of interatrial right-to-left shunts and also suggest the potential for prevention of recurrent embolism.
Study limitations
There are several limitations in our study. The major limitation of this study is that only a small number of patients were included and there were no available controlled data or comparative data. However, compared to classical PFO patients, we speculate the ASD patients with cryptogenic stroke are still rare. Another limitation is our selection of patients. Because we did not perform routine echocardiographic evaluation in patients with cerebrovascular stroke, our patients' profile may have some bias. Finally, our follow-up period is clearly too short to evaluate the efficacy for recurrent stroke prevention.
Conclusion
Although our study has some limitations, our data demonstrated the efficacy and safety of catheter closure for small ASD in patients with cryptogenic stroke. This relatively simple procedure can eliminate the risk of recurrent embolism, and the life-long anticoagulation treatment might be avoided.
